C
Christopher J. O'Donnell
Researcher at VA Boston Healthcare System
Publications - 914
Citations - 140860
Christopher J. O'Donnell is an academic researcher from VA Boston Healthcare System. The author has contributed to research in topics: Framingham Heart Study & Genome-wide association study. The author has an hindex of 159, co-authored 869 publications receiving 126278 citations. Previous affiliations of Christopher J. O'Donnell include Brown University & Veterans Health Administration.
Papers
More filters
Journal ArticleDOI
Strengthening the reporting of genetic risk prediction studies (GRIPS): explanation and elaboration.
A. Cecile J.W. Janssens,John P. A. Ioannidis,Sara Bedrosian,Paolo Boffetta,Siobhan M. Dolan,Nicole F. Dowling,Isabel Fortier,Andrew N. Freedman,Jeremy M. Grimshaw,Jeffrey R. Gulcher,Marta Gwinn,Mark A. Hlatky,Holly Janes,Peter Kraft,Stephanie Melillo,Christopher J. O'Donnell,Christopher J. O'Donnell,Michael J. Pencina,David F. Ransohoff,Sheri D. Schully,Daniela Seminara,Deborah M. Winn,Caroline F. Wright,Cornelia M. van Duijn,Julian Little,Muin J. Khoury +25 more
TL;DR: Eur J Clin Invest 2011; 41 (9): 1010–1035.
Posted Content
Metafrontier Functions for the Study of Inter-regional Productivity Differences
TL;DR: In this paper, the authors used the concept of metafrontier functions to study regional differences in production technologies and proposed a framework for the definition of met-frontier functions and the estimation of metfrontiers within the parametric framework of stochastic frontier analysis.
Journal ArticleDOI
Genetic factors contribute to the variance in frequency domain measures of heart rate variability
Jagmeet P. Singh,Martin G. Larson,Christopher J. O'Donnell,Christopher J. O'Donnell,Daniel Levy,Daniel Levy +5 more
TL;DR: Recognition of the genetic determinants of HRV may provide additional insight into the pathophysiology of the autonomic nervous system and offer clues toward its modulation.
Journal ArticleDOI
Cardiovascular genomics, personalized medicine, and the National Heart, Lung, and Blood Institute: part I: the beginning of an era.
TL;DR: The National Institutes of Health and the NHLBI are supporting a portfolio of large-scale genetic and genomic programs in diverse US populations with the longer-term objective of translating knowledge into the prediction, prevention, and preemption of CVD, as well as lung, sleep, and blood disorders.
Posted ContentDOI
The All of Us Research Program: data quality, utility, and diversity
Andrea H. Ramirez,Lina Sulieman,David J. Schlueter,Alese E. Halvorson,Jun Qian,Francis Ratsimbazafy,Roxana Loperena,Kelsey R. Mayo,Melissa A. Basford,Nicole A. Deflaux,Karthik N. Muthuraman,Karthik Natarajan,Abel N. Kho,Hua Xu,Consuelo H. Wilkins,Hoda Anton-Culver,Eric Boerwinkle,Mine S. Cicek,Cheryl R. Clark,Elizabeth Cohn,Lucila Ohno-Machado,Sheri D. Schully,Brian K. Ahmedani,Maria Argos,Robert M. Cronin,Christopher J. O'Donnell,Mona N. Fouad,David Goldstein,Philip Greenland,Scott J. Hebbring,Elizabeth W. Karlson,Parinda Khatri,Bruce R. Korf,Jordan W. Smoller,Stephen O. Sodeke,John Wilbanks,Justin Hentges,Christopher Lunt,Stephanie A. Devaney,Kelly Gebo,Joshua C. Denny,Robert J. Carroll,David Glazer,Paul A. Harris,George Hripcsak,Anthony Philippakis,Dan M. Roden +46 more
TL;DR: The initial release of cohort data contains longitudinal and multidimensional data on diverse participants that replicate known associations and the mission of All of Us to make data widely and securely available to researchers to improve human health and advance precision medicine is advanced.